Drew Weissman MD
Associate Professor, Medicine, Perelman School of Medicine
Join to view full profile
3900 Woodland AvePhiladelphia, PA 19104
Phone+1 215-823-5800
Dr. Weissman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1990 - 1993
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
Boston University School of MedicineClass of 1987
Certifications & Licensure
PA State Medical License 1997 - 2026
MD State Medical License 1990 - 1997
Publications & Presentations
PubMed
- 2 citationsTargeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.Khuloud Bajbouj, Zebin Xiao, Leslie Todd, Li Huang, Tyler E Papp
Cancer Immunology Research. 2026-04-02 - Prodrug-tethered lipid nanoparticles for synergistic messenger RNA cancer immunotherapy.Qiangqiang Shi, Ningqiang Gong, Jinjin Wang, Rohan Palanki, Qiuxian Zheng
Nature Nanotechnology. 2026-03-01 - 22 citationsCD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery.Tyler Ellis Papp, Jianhao Zeng, Hamna Shahnawaz, Awurama Akyianu, Laura Breda
Molecular Therapy. 2025-07-02
Press Mentions
Penn Medicine, Children’s Hospital of Philadelphia Team Awarded Breakthrough Prize for Developing Gene Therapy for Inherited BlindnessApril 18th, 2026- President’s Letter From Deb Palazzi – Celebration of the Quarter Century – the Annual St. Jude/PIDS Pediatric Infectious Diseases Research ConferenceMarch 11th, 2026
- Future mRNA Vaccines Could Offer Protection Against Food and Seasonal AllergiesSeptember 29th, 2025
Grant Support
- Individualized HIV Curative Combination Strategy against Persistent HIV on ARTWISTAR INSTITUTE2025–2030
- Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primatesUNIVERSITY OF PENNSYLVANIA2025–2030
- Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
- mVACS--mRNA Vaccines for C. difficile SuppressionUNIVERSITY OF PENNSYLVANIA2023–2028
- Vascular Targeting of Nanocarriers for RNAUNIVERSITY OF PENNSYLVANIA2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
